State MT
Clinical Trials in Montana
Montana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Montana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 35 actively recruiting studies with Montana sites out of 35 registered in total. The busiest research areas in Montana are Stage IVB Prostate Cancer AJCC v8, Acute Myeloid Leukemia, Lung Non-Small Cell Carcinoma. Leading sponsors running trials in the state include National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology. By stage, Montana trials break down as Phase 1 (1), Phase 2 (10), Phase 3 (19).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Montana
Stage IVB Prostate Cancer AJCC v8 (2)Acute Myeloid Leukemia (2)Lung Non-Small Cell Carcinoma (2)Chronic Lymphocytic Leukemia (2)Anatomic Stage II Breast Cancer AJCC v8 (2)Metastatic Castration-Resistant Prostate Carcinoma (1)Metastatic Prostate Adenocarcinoma (1)Recurrent Head and Neck Squamous Cell Carcinoma (1)Recurrent Hypopharyngeal Squamous Cell Carcinoma (1)Recurrent Laryngeal Squamous Cell Carcinoma (1)Recurrent Oral Cavity Squamous Cell Carcinoma (1)Recurrent Oropharyngeal Squamous Cell Carcinoma (1)
Frequently Asked Questions — Clinical Trials in Montana
How many clinical trials are currently recruiting in Montana?
ClinicalMetric currently tracks 35 actively recruiting clinical trials with at least one location in Montana. The total number of registered studies—including active but not currently enrolling trials—is 35. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Montana?
Montana hosts clinical trials across a broad range of medical conditions, including Stage IVB Prostate Cancer AJCC v8, Acute Myeloid Leukemia, Lung Non-Small Cell Carcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Montana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Montana?
To join a clinical trial in Montana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Montana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Montana
NCT06316297 Phase 1, Phase 2
Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Ad...
Condition
Acne
Enrollment
800 pts
Location
United States, Australia, Canada
Sponsor
Sanofi Pasteur, a Sanofi Compa
NCT04402788 Phase 2, Phase 3
Recruiting
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment ...
Condition
Extensive Stage Lung Small Cell Carcinoma
Enrollment
138 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04804644 Phase 3
Recruiting
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Who...
Condition
Metastatic Lung Small Cell Carcinoma
Enrollment
200 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT06997497 Phase 3
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy ...
Condition
Colon Adenocarcinoma
Enrollment
477 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06504589 N/A
Recruiting
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modu...
Condition
Cystic Fibrosis
Enrollment
400 pts
Location
United States
Sponsor
Nicole Hamblett
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT04267848 Phase 3
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemoth...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
1,210 pts
Location
United States, Guam
Sponsor
National Cancer Institute (NCI
NCT05254743 Phase 3
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chroni...
Condition
Chronic Lymphocytic Leukemia
Enrollment
737 pts
Location
United States, Argentina, Australia
Sponsor
Loxo Oncology, Inc.
NCT06876714 Phase 3
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People W...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
1,524 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT03851445 Phase 2, Phase 3
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung...
Condition
Previously Treated Non-Small Cell Lung Cancer
Enrollment
10,000 pts
Location
United States
Sponsor
SWOG Cancer Research Network
Page 2 of 2 — 35 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology